Skip to main content
Premium Trial:

Request an Annual Quote

NIH Awards $865K SBIR to QuantumBio to Develop Molecular Modeling Tools

NEW YORK (GenomeWeb News) - QuantumBio said yesterday that it has been awarded a Small Business Innovation Research grant worth more than $865,000 from the National Institutes of Health to develop molecular modeling software tools.
The two-year Phase II SBIR project will focus on developing quantum mechanics-based methods for studying protein/drug interactions. These methods “will ultimately lead to next generation molecular modeling tools used to aid pharmaceutical companies in developing more potent, less expensive drugs and drug-like compounds,” the company said in a statement.
In the first phase of the project, the company developed several novel interaction determination methods, which it validated against a number of enzyme targets. The Phase II project will focus on validating these methods with pharmaceutical industry partners, the company said.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.